New approaches in the diagnosis and therapy of myopic Choroidal neovascularization (CNV). Long-tem effects of anti-VEGF therapy for subfoveal myopic CNV. Best treatment drug: Bevacizumab versus Ranibizumab. Effects of treatment regimen. Effects of myopic CNV location (Juxtafoveal versus Extrafoveal myopic CNV). Agreement between FA and spectral domain OCT in detecting the activity of myopic subfoveal CNV

Choroidal neovascularization management in pathological myopia / Alessandro Papayannis - Udine. , 2012 May 19. 24. ciclo

Choroidal neovascularization management in pathological myopia

PAPAYANNIS, Alessandro
2012-05-19

Abstract

New approaches in the diagnosis and therapy of myopic Choroidal neovascularization (CNV). Long-tem effects of anti-VEGF therapy for subfoveal myopic CNV. Best treatment drug: Bevacizumab versus Ranibizumab. Effects of treatment regimen. Effects of myopic CNV location (Juxtafoveal versus Extrafoveal myopic CNV). Agreement between FA and spectral domain OCT in detecting the activity of myopic subfoveal CNV
19-mag-2012
Myopia; Choroidal neovascularization; Anti-VEGF therapy
Choroidal neovascularization management in pathological myopia / Alessandro Papayannis - Udine. , 2012 May 19. 24. ciclo
File in questo prodotto:
File Dimensione Formato  
10990_155_Management of mCNV A Papayannis pdf A.pdf

accesso aperto

Tipologia: Tesi di dottorato
Licenza: Non specificato
Dimensione 1.46 MB
Formato Adobe PDF
1.46 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11390/1132341
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact